Foreword. Part One: Electrophysiology. 1. Equipment for the electrophysiology laboratory; possibilities and limitations. 2. Vasovagal syncope: clinical presentation, classification and management. 3. Classification of antiarrhythmic drugs in relation to mechanisms of arrhythmias. 4. Electrophysiological characteristics in arrhythmogenic right ventricular dysplasia and dilated cardiomyopathies. 5. Classification of death in patients under antiarrhythmic treatment. 6. Heart rate variability. Methodology and physiological ...
Read More
Foreword. Part One: Electrophysiology. 1. Equipment for the electrophysiology laboratory; possibilities and limitations. 2. Vasovagal syncope: clinical presentation, classification and management. 3. Classification of antiarrhythmic drugs in relation to mechanisms of arrhythmias. 4. Electrophysiological characteristics in arrhythmogenic right ventricular dysplasia and dilated cardiomyopathies. 5. Classification of death in patients under antiarrhythmic treatment. 6. Heart rate variability. Methodology and physiological basis. 7. Heart rate variability and QT interval: their relationship with the cardiac frequency. 8. Role of dynamic QT interval in Holter tapes to stratify risk in postmyocardial infarction patients. 9. Heart rate variability in patients with angina pectoris. 10. Time and frequency domain analysis of heart rate variability after myocardial infarction. 11. Signal averaged ECG. Technical principles, possibilities and limitations. 12. Optimizing the predictive value of the signal-averaged ECG for serious arrhythmic events in the post-infarction period. 13. Signal-averaged analysis of the P wave: possible applications in different settings. 14. Late potentials during acute myocardial ischaemia. 15. Radiofrequency catheter ablation in the treatment of supraventricular tachycardias. 16. Anatomical versus electrophysiological approaches for ablation of the slow pathway in patients with AV nodal reentrant tachycardia. Part Two: Pacing. 17. Cardiac pacing in Europe in 1992: a new survey. 18. The myocardium-electrode interface at the cellular level. 19. The myocardium-electrode interface at the macrolevel. 20. Unipolar versus bipolar leads. 21. Single lead VDD pacing: an update. 22. Substantial improvement of screw-in electrodes. 23. Physiological cardiac pacing: an individual objective. 24. Pacemaker syndrome during atrial-based pacing. 25. Dual chamber pacemaker therapy in cardiomyopathy. 26. DDD rate-responsive pacing: state of the art. 27. Heart rate response based on changes in central venous oxygen saturation, minute ventilation and body activity. 28. DDDR and atrial arrhythmia. 29. Holter and pacemaker diagnostics. 30. Clinical relevance of histograms in the follow-up of DDDR-pacemakers. 31. Holter and telemetry in pacemakers and ICDs: new developments. 32. Automatic measure of the interface capacitor and the total cardiac impedance. 33. Critical analysis of the different algorithms designed to protect the paced patient against atrial tachyarrhythmias in dual chamber pacing. 34. Mode switching in DDDR pacing. Part Three: Defibrillators. 35. Indication for ICD implantation and selection of patients: present and future. 36. The optimum tilt for defibrillation. 37. Cerebrovasomotor reactivity predicts tolerance to tiered therapy with implantable cardioverter-defribillators. 38. Clinical utility of telemetered electrograms in pacemakers and ICD's. 39. High patient acceptance for implantable cardioverter/defribillator (ICD); quality of life and patient acceptance. 40. Cardiac pacing and electrophysiology: how much technology do we need? 41. Medical technology assessment and reimbursement policy of implantable device
Read Less
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. Sewn binding. Cloth over boards. 468 p. Contains: Unspecified. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Sewn binding. Cloth over boards. 468 p. Contains: Unspecified. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Sewn binding. Cloth over boards. 468 p. Contains: Unspecified. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.